GLP-1 Platform Vendors
Detailed profiles for 20 GLP-1 management platforms — from PBM-integrated programs like Optum and CVS Caremark to dedicated clinical platforms like Noom Med, Calibrate, and Virta Health. Compare prior authorization protocols, clinical oversight models, lifestyle support, PBM integration, and published outcomes.
Disclaimer: This content is for informational purposes only and does not constitute legal, financial, or benefits advice. Consult qualified ERISA counsel and licensed advisors before making plan decisions.
GLP-1 Management Buyer's Guide
PBM-Integrated vs. Standalone
PBM-integrated programs (Optum, Caremark, ESI) offer seamless pharmacy management but less clinical depth. Standalone platforms (Noom Med, Calibrate, Virta) deliver better outcomes and lifestyle support but require PBM coordination. Choose based on your PBM relationship and clinical management priorities.
Clinical Criteria & Prior Auth
Require evidence-based clinical criteria: BMI ≥30 (or ≥27 with comorbidity), documented lifestyle intervention failure, and no contraindications. Mandatory prior authorization with clinical review reduces inappropriate utilization by 30–50% without denying access to clinically appropriate patients.
Lifestyle Support Is Non-Negotiable
GLP-1 medications without behavioral support have high discontinuation rates (50%+ within 12 months) and weight regain on cessation. Require vendors to demonstrate behavioral coaching, nutrition support, and a structured maintenance/taper program as part of the clinical model.
Outcomes Measurement
Require vendors to report: weight loss at 6 and 12 months, A1c reduction (for T2D cohort), medication adherence rates, discontinuation rates, and downstream medical cost impact. Vendors without published peer-reviewed outcomes or employer-specific data should be treated as unproven.
PBM Integration Requirements
Confirm the vendor integrates with your specific PBM for real-time prior authorization, formulary management, and claims data. Poor PBM integration creates administrative burden, delays in care, and gaps in outcomes measurement. Ask for a technical integration spec before contracting.
Cost Management Strategy
GLP-1 costs are manageable with the right strategy: clinical criteria reduce inappropriate utilization, specialty pharmacy carve-out reduces drug cost, outcomes-based contracts align vendor incentives, and maintenance programs reduce long-term dependency. Budget $8,000–$12,000 net per managed patient per year.
Frequently Asked Questions
What is a GLP-1 management platform and why do employers need one?
GLP-1 receptor agonists (Ozempic, Wegovy, Mounjaro, Zepbound) are among the most effective medications for obesity and Type 2 diabetes, but they cost $12,000–$18,000 per patient per year. Without clinical management, employers face runaway costs and poor outcomes. A GLP-1 management platform provides prior authorization, step therapy, clinical oversight, lifestyle support, and outcomes measurement to ensure appropriate utilization and measurable ROI.
How much can a GLP-1 management program save employers?
Effective GLP-1 management programs reduce inappropriate utilization by 20–40%, improve adherence and outcomes, and can deliver $3–$6 PMPY savings in high-risk populations through reduced diabetes complications, cardiovascular events, and hospitalizations. The ROI depends on your population's GLP-1 utilization rate, clinical criteria rigor, and lifestyle support engagement.
What clinical criteria should employers require for GLP-1 coverage?
Evidence-based criteria: BMI ≥30 (or ≥27 with weight-related comorbidity), documented failure of lifestyle intervention, no contraindications (pancreatitis history, MEN2, thyroid cancer), and for diabetes indications, A1c ≥7.0% on existing therapy. These criteria reduce inappropriate utilization by 30–50% while ensuring access for clinically appropriate patients.
Disclaimer: This content is for informational purposes only and does not constitute legal, financial, or benefits advice. Consult qualified ERISA counsel and licensed advisors before making plan decisions.